Chemotherapy and novel proton radiotherapy in spatially advanced multicellular models of pancreatic cancer: On the design of platform for enabling low cost animal free preclinical treatment testing Abstract
Article Sidebar
Main Article Content
Abstract
With a 5-year of only 11% pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest diseases. This is partly attributed to the tumour’s resistance to currently available treatment, resulting from a complex and highly heterogeneous tumour microenvironment (TME). A key challenge in cancer tissue engineering is to mimic the different key features of the TME. In this work we have developed robust, PDAC biomimetic models for in vitro therapeutic assessment.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:
- the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
- the right to produce prepublications, reprints, and special editions of the Manuscript;
- the right to translate the Manuscript into other languages;
- the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
- the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers;
- the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
- the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.
How to Cite
Funding data
-
Medical Research Council
Grant numbers MR/V028553/1
References
Totti S, Allenby MC, Dos Santos SB, Mantalaris A, Velliou E. A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma, RSC Adv. 2018; 8: 20928-20940 https://doi.org/10.1039/C8RA02633E
Gupta P, Totti S, Pérez-Mancera PA, Dyke E, Nisbet A, Schettino G, Webb R, Velliou EG. Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. RSC Adv. 2019; 9: 41649-41663 https://doi.org/10.1039/C9RA09123H
Gupta P, Pérez-Mancera PA, Kocher H, Nisbet A, Schettino G, Velliou EG. A novel scaffold-based hybrid multicellular model for pancreatic ductal adenocarcinoma—toward a better mimicry of the in vivo tumor microenvironment. Front. Bioeng. Biotechnol. 2020; 8 (290). https://doi.org/10.3389/fbioe.2020.00290
Gupta P, Bermejo-Rodriguez C, Kocher H, Pérez-Mancera PA, Velliou EG. Chemotherapy assessment in advanced multicellular 3D models of pancreatic cancer: Unravelling the importance of spatiotemporal mimicry of the tumor microenvironment. Adv. Biol. 2024; 2300580. https://doi.org/10.1002/adbi.202300580